Menu
CDMO Services
Expand menu
Overview
Analytics
Process Development
Manufacturing
Meet Us
Platforms
Expand menu
LentiVector® platform
inAAVate™ platform
About us
Expand menu
Overview
Our people
News
Sustainability
Careers
Investors
Expand menu
Analyst coverage
Registrars
Investor contacts
Share price information
Results, reports, presentations & webcasts
Regulatory news
Shareholder meetings, circulars & prospectuses
Corporate governance
Board committees
Warning to shareholders
Investor events and conferences
Contact us
CDMO Services
Overview
Analytics
Process Development
Manufacturing
Meet Us
Platforms
LentiVector® platform
inAAVate™ platform
About us
Overview
Our people
News
Sustainability
Careers
Investors
Analyst coverage
Registrars
Investor contacts
Share price information
Results, reports, presentations & webcasts
Regulatory news
Shareholder meetings, circulars & prospectuses
Corporate governance
Board committees
Warning to shareholders
Investor events and conferences
Contact us
Menu
Oxb 40x*
10 February 2017
Continue reading
OXB-40X*
Undisclosed liver indication.